| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.4M | — | +198.9% |
| Cost of Revenue | $3.0M | — | +193.4% |
| Gross Profit | $1.4M | — | +211.8% |
| R&D Expense | $20.0M | — | +29.1% |
| SG&A Expense | $7.4M | — | +11.4% |
| Operating Income | -$26.0M | — | -20.0% |
| Pre-tax Income | $33.1M | — | -22.3% |
| Net Income | $33.1M | — | -22.3% |
| EPS (Basic) | $0.10 | — | -33.3% |
| EPS (Diluted) | -$0.06 | — | -146.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.1M | +7.3% | +29.6% |
| Accounts Receivable | $4.4M | +71.5% | +309.7% |
| Current Assets | $432.2M | -5.0% | +101.6% |
| Total Assets | $650.7M | -2.4% | +141.8% |
| Current Liabilities | $61.9M | +409.2% | +443.2% |
| Total Liabilities | $67.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.2M | — | -18.8% |
| Capital Expenditures | $4.4M | — | +73.2% |
| Investing Cash Flow | $19.8M | — | +183.9% |
| Financing Cash Flow | $81K | — | -98.8% |
| Free Cash Flow | -$20.6M | — | -27.3% |
| +8.2% |
| Stockholders' Equity | $583.6M | +6.8% | +181.8% |